90th General Assembly · Iowa Funnel one-pager · Tuesday, November 10, 2026
SF 168: Prohibiting certain advertising of prescription drugs in the state and providing penalties
Died when the session ended · The 2024 session adjourned on April 19, 2024, the General Assembly’s last regular session. Bills that didn’t pass both chambers died.
What it does
This bill prohibits the advertising of prescription drugs, either by broadcast by a television or radio station in this state, over the internet from a location in this state, or in a magazine or newspaper printed, distributed, or sold in this state. A violation of the bill is a serious misdemeanor. A serious misdemeanor is punishable by confinement for no more than one year and a fine of at least $430 but not more than $2,560. Each day a manufacturer is in violation of the bill is considered a separate violation. A violation of the bill is also an unlawful practice under Code section 714.16 (consumer frauds) which includes enforcement provisions relating to injunctive relief and other relief and civil penalties.
Sponsors
Not listed
Cost
No fiscal note
Senate subcommittee · named February 2, 2023
- Sen. Jeff Edler (R)
- Sen. Mark Costello (R) · mark.costello@legis.iowa.gov
- Sen. Pam Jochum (D)
Lobbying · 1 for, 5 against
For: Next Generation of Cystinosis
Against: Bristol Myers Squibb Co.; Eli Lilly & Co.; Merck Sharp & Dohme LLC; Pfizer Inc. c/o Politicom Law LLP; Pharmaceutical Research and Manufacturers of America (PhRMA)
In plain words
- January 30, 2023Filed in the Senate and sent to the Health and Human Services committee
- February 2, 2023Senate subcommittee named: Edler, Costello and Jochum
From public records at legis.iowa.gov, compiled by Iowa Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Tuesday, November 10, 2026. https://iowafunnel.com/bills/90/SF168